Marianne Heibert Arnlind
Karolinska Institutet
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marianne Heibert Arnlind.
Acta Oncologica | 2013
Eva Johansson; Fredrik Hammarskjöld; Dag Lundberg; Marianne Heibert Arnlind
Abstract Background. The use of central venous lines carries a significant risk for serious complications and high economic costs. Lately, the peripherally inserted central venous catheter (PICC) has gained in popularity due to presumed advantages over other central venous lines. The aim of this systematic literature review was to identify scientific evidence justifying the use of PICC. Material and methods. The literature review was performed according to the principles of Cochrane Collaboration. The electronic literature search included common databases up to March 2011. Only those studies rated as high or moderate quality were used for grading of evidence and conclusions. Results. The search resulted in 827 abstracts, 48 articles were read in full text, and 11 met the inclusion criteria. None of the articles was classified as high quality and two had moderate quality. The results of these two studies indicate that PICC increases the risk for deep venous thrombosis (DVT), but decreases the risk for catheter occlusion. The quality of scientific evidence behind these conclusions, however, was limited. Due to the lack of studies with sufficiently high quality, questions such as early complications, patient satisfaction and costs could not be answered. Discussion. We conclude that although PICCs are frequently used in oncology, scientific evidence supporting any advantage or disadvantage of PICC when comparing PICC with traditional central venous lines is limited, apart from a tendency towards increased risk for DVT and a decreased risk for catheter occlusion with PICC.
BMC Medical Imaging | 2012
Edward Azavedo; Sophia Zackrisson; Ingegerd Mejàre; Marianne Heibert Arnlind
BackgroundIn accordance with European guidelines, mammography screening comprises independent readings by two breast radiologists (double reading). CAD (computer-aided detection) has been suggested to complement or replace one of the two readers (single reading + CAD).The aim of this systematic review is to address the following question: Is the reading of mammographic x-ray images by a single breast radiologist together with CAD at least as accurate as double reading?MethodsThe electronic literature search included the databases Pub Med, EMBASE and The Cochrane Library. Two independent reviewers assessed abstracts and full-text articles.Results1049 abstracts were identified, of which 996 were excluded with reference to inclusion and exclusion criteria; 53 full-text articles were assessed for eligibility. Finally, four articles were included in the qualitative analysis, and one in a GRADE synthesis.ConclusionsThe scientific evidence is insufficient to determine whether the accuracy of single reading + CAD is at least equivalent to that obtained in standard practice, i.e. double reading where two breast radiologists independently read the mammographic images.
The Breast | 2016
Lisa Rydén; Marianne Heibert Arnlind; Sigurd Vitols; Malin Höistad; Johan Ahlgren
Tamoxifen (TAM) and aromatase inhibitors (AI) are adjuvant therapy options for postmenopausal women with estrogen receptor positive (ER+) breast cancer. This systematic review of seven randomized controlled studies comparing TAM and AI, and one study comparing extended therapy with an AI with placebo after about 5 years of tamoxifen, aims to assess long-term clinical efficacy and adverse events. The literature review was performed according to the principles of the Cochrane Collaboration. The search included common databases up to 2013-01-14. Studies of high or moderate quality were used for grading of evidence. Revman™ software was utilized for meta-analyses of published data. Disease free survival (DFS) and overall survival (OS) were improved with AI monotherapy compared to TAM with high and moderate quality of evidence respectively. Sequenced therapy with AI → TAM (or vice versa) improved DFS compared with TAM with moderate quality of evidence, but did not improve OS (low quality of evidence). However, if only studies on sequenced AI therapy with randomization before endocrine therapy were considered, no improvement of DFS could be found. Fractures are more frequently associated with AI whereas the risk of endometrial cancer and venous thromboembolism are higher with TAM. For cardiovascular events no difference was found between AI (mono- or sequenced therapy) and TAM, whereas sequenced therapy compared with AI had lower risk of cardiovascular events (moderate level of evidence). AIs are superior to TAM as adjuvant hormonal therapy for postmenopausal ER-positive breast cancer. TAM can be considered for individual patients due to the different toxicity profile compared with AI. Cardiovascular events related to AI treatment deserve further attention.
Acta Obstetricia et Gynecologica Scandinavica | 2017
Erik Iwarsson; Bo Jacobsson; Jessica Dagerhamn; Thomas Davidson; Eduardo Bernabé; Marianne Heibert Arnlind
The aim of this study was to review the performance of non‐invasive prenatal testing (NIPT) for detection of trisomy 21, 18 and 13 (T21, T18 and T13) in a general pregnant population as well as to update the data on high‐risk pregnancies.
Journal of Asthma | 2006
Marianne Heibert Arnlind; Mika Nokela; Clas Rehnberg; Eva Wikström Jonsson
The objective of this study is to explore the relationship between variables that may influence pharmaceutical costs in asthma and to generate a predictive model for these costs in primary health care. The understanding of these relationships is important since costs of drugs may place unnecessary economic burden on patients and society. During 2003, prospective clinical data were collected from 105 patients in 24 primary health care centers located in Stockholm. The relationships between cost of drugs and quality of life, lung function, and asthma severity were analyzed in a regression model. Twenty-three percent of the observed variation in pharmaceutical costs could be explained by asthma severity, disease-specific quality of life, and clinical practice. There was a weak inverse correlation between pharmaceutical costs, generic quality of life, and lung function. Even when severity was accounted for, there were large variations in costs between different primary health care units.
Acta Oncologica | 2013
Eva Johansson; Fredrik Hammarskjöld; Dag Lundberg; Marianne Heibert Arnlind
iodine-131 for ablation of differentiated thyroid cancers . J Pak Med Assoc 2006 ; 56 : 353 – 6 . Sasitorn S , Vacharee B , Panya P , Supatporn T , Supot B . [5] Prospective randomized trial for evaluation of effi cacy of low versus high dose I-131 for postoperative remnant ablation in differentiated thyroid cancer . Chula Med J 2006 ; 50 : 695 – 706 . Pilli T , Brianzoni E , Capoccetti F , Castagna MG , Fattori S , [6] Poggiu A , et al . A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer . J Clin Endocrinol Metab 2007 ; 92 : 3542 – 6 . Engels EA , Schmid CH , Terrin N , Olkin I , Lau J . [7] Heterogeneity and statistical signifi cance in meta-analysis: An empirical study of 125 meta-analyses . Stat Med 2000 ; 19 : 1707 – 28 . References
Clinical and Translational Allergy | 2015
Sven-Arne Jansson; Eva Östblom; Jennifer L.P. Protudjer; Marianne Heibert Arnlind; Ulf Bengtsson; Ingrid Kallström-Bengtsson; Birgitta Marklund; Roelinde Middelveld; Georgios Rentzos; Ann-Christine Sundqvist; Johann Åkerström; Sven-Erik Dahlén; Staffan Ahlstedt
Methods Swedish children (0-12 years) and adolescents (13-17 years) with objectively diagnosed food allergy to staple foods were recruited in an outpatient allergy clinic. Ageand sex-matched controls were included. Food-allergic adolescents themselves and the parents of food-allergic children answered a food-allergy specific HRQL questionnaire (FAQLQ), developed within EuroPrevall. A generic HRQL questionnaire, EQ-5D, was answered by parents to cases and controls. In total, 85 children and 58 adolescents (cases), and 94 children and 56 adolescents (controls) participated.
Journal of Asthma | 2013
Marianne Heibert Arnlind; Björn Wettermark; Bengt Sjöborg; Elin Dahlén; Desirée Loikas; Eva Wikström Jonsson
Abstract Introduction: Socioeconomic status (SES) is strongly associated with morbidity as well as with health care utilization and expenditure. The association between SES and quality of prescribing of asthma drugs is less studied. Objectives: The aim of this study was to examine the association between socioeconomic factors, i.e. education, income and country of birth, and the prevalence, incidence and adherence to guidelines for antiasthmatic drugs. Methods: This registry study includes all Swedish citizens aged 25–44 years who redeemed at least one prescription of an antiasthmatic drug during 2010. Incidence and prevalence was calculated. The adherence to guidelines was studied using two defined quality indicators. Heavy users were also assessed. Results: Incidence for antiasthmatic drugs was 18.4 per 1000 person-years and the prevalence 50.9 per 1000 inhabitants. Previously untreated patients who redeemed fixed combination ranged from 45% to 49%. Patients who purchase long-acting beta-2-adrenoceptor agonists (LABA) without inhaled corticosteroid ranged from 43% to 59%. Six percent of the population was classified as heavy users. Conclusion: The study showed a high incidence and prevalence of asthma drug use with a poor adherence to guidelines for rational drug prescribing. Fixed combination as first line asthma treatment as well as purchasing LABA without concomitant ICS was more common in patients born outside Scandinavia. Heavy users of short-acting bronchodilators were associated with male sex, high age, low income levels and low levels of education.
European Journal of Clinical Pharmacology | 2010
Marianne Heibert Arnlind; Björn Wettermark; Mika Nokela; Paul Hjemdahl; Clas Rehnberg; Eva Wikström Jonsson
The Journal of Allergy and Clinical Immunology: In Practice | 2015
Jennifer L.P. Protudjer; Sven-Arne Jansson; Marianne Heibert Arnlind; Ulf Bengtsson; Ingrid Kallström-Bengtsson; Birgitta Marklund; Roelinde Middelveld; Georgios Rentzos; Ann-Charlotte Sundqvist; Johanna Åkerström; Eva Östblom; Sven-Erik Dahlén; Staffan Ahlstedt